Plaudit

Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer

  • Brendan J. Guercio
  • , Eugene J. Pietzak
  • , Vignesh Ravichandran
  • , Jie-Fu Chen
  • , Ronak H. Shah
  • , Vanessa Peters
  • , Ashley M. Regazzi
  • , Scot A. Niglio
  • , David H. Aggen
  • , Samuel A. Funt
  • , Timothy F. Donahue
  • , Alvin C. Goh
  • , Eugene K. Cha
  • , Phillip Wong
  • , Allison L. Richards
  • , Cassidy C. Cobbs
  • , S. Machele Donat
  • , Guido Dalbagni
  • , Bernard H. Bochner
  • , Gopa Iyer
  • , Mark T.A. Donoghue
  • , Irina Ostrovnaya
  • , Hikmat A. Al-Ahmadie
  • , Jonathan E. Rosenberg
  • , Min Yuen Teo

No endorsements

This article has not been endorsed yet.

Like this work?

Let others know. Sign in to add your endorsement.